Asset
Ataluren
PTC Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00234663 | phase2 | completed | 2005-09-01 | 2006-08-01 | PTC Therapeutics | PTC124 for Cystic Fibrosis |
| NCT00351078 | phase2 | completed | 2006-12-01 | 2007-07-01 | PTC Therapeutics | PTC124 for the Treatment of Cystic Fibrosis |
| NCT00264888 | phase2 | completed | 2005-12-01 | 2007-05-01 | PTC Therapeutics | Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy |
FDA applications (0)
This company has no applications containing this asset.